These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22525398)

  • 1. Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children.
    Fiocchi A; Omboni S; Mora R; Macchi A; Nespoli L; Arrigoni S; Guastini L; Castelnuovo P; Graziani D; Marcassa S
    Allergy Asthma Proc; 2012; 33(2):197-204. PubMed ID: 22525398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome-component immune modulation of respiratory tract infections in children.
    Fiocchi A; Terracciano L; Martelli A; Bernardo L; Calcinai E; Marcassa S
    Allergy Asthma Proc; 2009; 30 Suppl 1():S21-31. PubMed ID: 19679002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of ribosome-component immune modulator in adults and children.
    Olivieri D; Fiocchi A; Pregliasco F; Veehof S; Cantoni V
    Allergy Asthma Proc; 2009; 30 Suppl 1():S33-6. PubMed ID: 19679003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome-component immune modulation of respiratory tract infections in adults.
    Olivieri D; Chiesa S; Tzani P; Marino P; Robberto E; Marcassa S
    Allergy Asthma Proc; 2009; 30 Suppl 1():S13-9. PubMed ID: 19679001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ribosome-component immune modulator for preventing recurring respiratory infections in socialized children.
    Bergamini M; Simeone G; Verga MC; Fiocchi A; Omboni S
    Allergy Asthma Proc; 2013; 34(1):108-9. PubMed ID: 23406944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment using immucytal in children with recurrent respiratory infections: an Italian multicenter experience].
    Fiocchi A; Vignati B; Cinquepalmi P; Machado E; Peano L; Pulejo R; Puleo G; Lietti D; Merazzi D; Caramia G
    Pediatr Med Chir; 1989; 11(3):285-91. PubMed ID: 2687818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.
    Taylor JA; Weber W; Standish L; Quinn H; Goesling J; McGann M; Calabrese C
    JAMA; 2003 Dec; 290(21):2824-30. PubMed ID: 14657066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
    Esposito S; Bianchini S; Bosis S; Tagliabue C; Coro I; Argentiero A; Principi N
    J Transl Med; 2019 Aug; 17(1):284. PubMed ID: 31443716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial.
    Fintelmann V; Albrecht U; Schmitz G; Schnitker J
    Curr Med Res Opin; 2012 Nov; 28(11):1799-807. PubMed ID: 23083066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.
    Grimfeld A; Holgate ST; Canonica GW; Bonini S; Borres MP; Adam D; Canseco Gonzalez C; Lobaton P; Patel P; Szczeklik A; Danzig MR; Roman I; Bismut H; Czarlewski W
    Clin Exp Allergy; 2004 Nov; 34(11):1665-72. PubMed ID: 15544588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults.
    Bellanti J; Olivieri D; Serrano E
    BioDrugs; 2003; 17(5):355-67. PubMed ID: 14498765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV; Berber A
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
    Careddu P; Mei V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1485-9. PubMed ID: 7857348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study.
    Souza FC; Mocellin M; Ongaratto R; Leitão LAA; Friedrich FO; Silveira VD; Scotta MC; Pitrez PM; Pinto LA
    Einstein (Sao Paulo); 2020; 18():eAO5262. PubMed ID: 32130328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preventive measure for otitis media in children with upper respiratory tract infections.
    Mora R; Barbieri M; Passali GC; Sovatzis A; Mora F; Cordone MP
    Int J Pediatr Otorhinolaryngol; 2002 Apr; 63(2):111-8. PubMed ID: 11955602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy.
    Manti S; Parisi GF; Papale M; Licari A; Salpietro C; Miraglia Del Giudice M; Marseglia GL; Leonardi S
    Ital J Pediatr; 2020 Apr; 46(1):42. PubMed ID: 32245500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C; Gentile DA; Skoner DP
    Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
    Careddu P
    Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.